Benefit of angiotensin II receptor blockade in the treatment of posttransplant polycythemia in renal transplant recipients

被引：8

作者：

Kupin, W ^{[1
]}

Venkat, KK ^{[1
]}

Goggins, M ^{[1
]}

Abouljoud, M ^{[1
]}

Escobar, F ^{[1
]}

Mozes, M ^{[1
]}

机构：

[1] HENRY FORD HOSP, DEPT TRANSPLANTAT SURG, DETROIT, MI 48202 USA

来源：

关键词：

D O I：

10.1016/S0041-1345(96)00065-6

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：207 / 208

页数：2

共 6 条

[1]

CONLON PJ, 1993, TRANSPLANTATION, V56, P217

[2]

GASTON RS, 1994, AM J KIDNEY DIS, V24, P1

[3] ANGIOTENSIN RECEPTOR ANTAGONISTS - FOCUS ON LOSARTAN [J].

JOHNSTON, CI .

LANCET, 1995, 346 (8987) :1403-1407

KANG, PM ;

LANDAU, AJ ;

EBERHARDT, RT ;

FRISHMAN, WH .

[5] FACTORS PREDICTIVE OF POSTTRANSPLANT ERYTHROCYTOSIS [J].

QUNIBI, WY ;

BARRI, Y ;

DEVOL, E ;

ALFURAYH, O ;

SHETH, K ;

TAHER, S .

[6]

Sumrani N B, 1993, ASAIO J, V39, P51, DOI 10.1097/00002480-199301000-00012